KK
CGON icon

KLP Kapitalforvaltning’s CG Oncology CGON Stock Holding History

KLP Kapitalforvaltning’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$643K Buy
9,500
+400
+4% +$22.7K ﹤0.01% 1289
2025
Q4 		$378K Buy
9,100
+1,000
+12% +$41.4K ﹤0.01% 1550
2025
Q3 		$326K Hold
8,100
– – ﹤0.01% 1619
2025
Q2 		$211K Hold
8,100
– – ﹤0.01% 1768
2025
Q1 		$198K Buy
8,100
+4,600
+131% +$129K ﹤0.01% 1746
2024
Q4 		$100K Buy
+3,500
New +$120K ﹤0.01% 2086

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

KLP Kapitalforvaltning's CGON Position: Q1 2026 in Review

KLP Kapitalforvaltning increased its CG Oncology (CGON) stake by 4.4% in Q1 2026, buying an estimated $22.7K and bringing the position to 9,500 shares worth $643K. The position accounts for ﹤0.01% of the portfolio, ranked #1289.

KLP Kapitalforvaltning first reported a position in CGON in Q4 2024 and has held it in 6 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • KLP Kapitalforvaltning held 9,500 shares of CG Oncology worth $643K as of Q1 2026.
  • KLP Kapitalforvaltning bought 400 CG Oncology shares in Q1 2026, an estimated $22.7K.
  • CG Oncology made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #1289 holding.
  • KLP Kapitalforvaltning first reported a position in CG Oncology in Q4 2024 and has held it in 6 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.